Mindera Health Announces Commercial Relocation
November 27, 2023 08:00 ET
|
Mindera Health
San Diego, CA, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, a leading provider of precision medicine solutions for psoriasis, today announced that it will be relocating its commercial...
Mindera Health ™ announces the signing of a commercial agreement with Occum Health for Mind.Px ™
November 06, 2023 08:00 ET
|
Mindera Health
San Diego, CA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announces the signing a commercial agreement with Occum Health, LLC, a healthcare solutions company that is focused on...
Mindera Inc. Signs Provider Contract with Provider Network Contigo Health ConfigureNet(™)
October 23, 2023 08:00 ET
|
Mindera Health
San Diego, CA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, announces that it has signed a provider contract...
Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
October 16, 2023 08:00 ET
|
Mindera Health
San Diego, CA, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mindera Health, a precision medicine company developing personalized tools to optimize patient outcomes, today announced that additional patent...
Mindera Health™ Announces Contract With General Services Administration®
October 10, 2023 08:00 ET
|
Mindera Health
San Diego, CA, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Mindera Health today announced that the General Services Administration (GSA) has granted a 5 year contract award to Mindera Health enabling access...
Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
October 03, 2023 10:00 ET
|
Mindera Health
San Diego, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider...
Mindera Health™ Announces Change to Executive Leadership Team
May 11, 2023 15:57 ET
|
Mindera Health
San Diego, CA, May 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive...
Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending
April 11, 2023 09:00 ET
|
Mindera Health
San Diego, CA, April 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, has initiated a coverage with evidence project...
Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer
March 14, 2023 08:00 ET
|
Mindera Health
San Diego, CA, March 14, 2023 (GLOBE NEWSWIRE) -- Mindera Health, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has appointed Mr. Linh H. Le as Chief Financial...
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients
October 20, 2022 08:00 ET
|
Mindera Health
San Diego, CA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at...